Skip to main content
Full access
Regular Articles
Published Online: 5 March 2018

Pseudobulbar Affect Correlates With Mood Symptoms in Parkinsonian Disorders but Not Amyotrophic Lateral Sclerosis

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

Pseudobulbar affect (PBA) is a syndrome of affective disturbance associated with inappropriate laughter and crying, independent of mood. PBA is common in amyotrophic lateral sclerosis (ALS) and increasingly recognized in Parkinson’s disease (PD) and atypical parkinsonism (aP). Correlates of PBA have not been systematically studied. The purpose of this study was to determine whether cognitive and psychiatric comorbidities correlated with patient-reported symptoms of PBA by using the Center for Neurological Study–Lability Scale among patients with ALS, PD, and aP. A total of 108 patients (PD, N=53; aP, N=29; ALS, N=26) completed a cognitive screener and self-reported measures of lability, depression, anxiety, apathy, and quality of life. Statistical analyses included one- and two-way analyses of covariance to evaluate group differences, Pearson’s correlations to determine relationships between PBA symptoms and comorbidities, multiple regression for predicting PBA symptom severity in clinical correlates, and chi-square t tests for predicting demographic variables. PBA symptom severity did not vary between the three groups. Younger age and worse anxiety correlated with PBA symptom severity in all three groups, whereas depression and poor mental health/quality of life only correlated with PBA symptom severity in the PD and aP groups. PD and aP patients may be more likely to benefit from treatment with antidepressants. Increased PBA symptoms were associated with declines in cognitive functioning in the aP group, but sufficient numbers of PD and ALS patients with cognitive dysfunction may not have been recruited. The results suggest the possibility of an alternate pathophysiologic mechanism for PBA, which may vary between neurological disorders and disease progression. Mood and cognition are of particular relevance and should be evaluated when symptoms of PBA are suspected.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 214 - 219
PubMed: 29505320

History

Received: 2 July 2017
Revision received: 1 September 2017
Accepted: 1 October 2017
Published online: 5 March 2018
Published in print: Summer 2018

Keywords

  1. pseudobulbar affect
  2. Parkinsonism
  3. amyotrophic laterosclerosis
  4. Depression
  5. anxiety

Authors

Details

Neepa Patel, M.D. [email protected]
From the Parkinson Disease and Movement Disorders Clinic, Henry Ford Hospital West Bloomfield, Mich. (NP); the Department of Psychology, University of Kentucky, Lexington, K.Y. (HC); the Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Tex. (MY, JJ-S); the ALS Association Center, Baylor College of Medicine, Houston, Tex. (MY); and the Department of Medicine, University of Alberta, Alberta, CA (CP).
Hannah Combs, Ph.D.
From the Parkinson Disease and Movement Disorders Clinic, Henry Ford Hospital West Bloomfield, Mich. (NP); the Department of Psychology, University of Kentucky, Lexington, K.Y. (HC); the Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Tex. (MY, JJ-S); the ALS Association Center, Baylor College of Medicine, Houston, Tex. (MY); and the Department of Medicine, University of Alberta, Alberta, CA (CP).
Michele York, Ph.D.
From the Parkinson Disease and Movement Disorders Clinic, Henry Ford Hospital West Bloomfield, Mich. (NP); the Department of Psychology, University of Kentucky, Lexington, K.Y. (HC); the Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Tex. (MY, JJ-S); the ALS Association Center, Baylor College of Medicine, Houston, Tex. (MY); and the Department of Medicine, University of Alberta, Alberta, CA (CP).
Cecile Phan, M.D.
From the Parkinson Disease and Movement Disorders Clinic, Henry Ford Hospital West Bloomfield, Mich. (NP); the Department of Psychology, University of Kentucky, Lexington, K.Y. (HC); the Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Tex. (MY, JJ-S); the ALS Association Center, Baylor College of Medicine, Houston, Tex. (MY); and the Department of Medicine, University of Alberta, Alberta, CA (CP).
Joohi Jimenez-Shahed, M.D.
From the Parkinson Disease and Movement Disorders Clinic, Henry Ford Hospital West Bloomfield, Mich. (NP); the Department of Psychology, University of Kentucky, Lexington, K.Y. (HC); the Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Tex. (MY, JJ-S); the ALS Association Center, Baylor College of Medicine, Houston, Tex. (MY); and the Department of Medicine, University of Alberta, Alberta, CA (CP).

Notes

Send correspondence to Dr. Patel; email: [email protected]

Funding Information

National Institute of Mental Health10.13039/100000025: 104673, 60836, 66984
Pritzker-Pucker Family Foundation: NA
Dr. Patel has received honoraria as a consultant for Acadia Pharmaceuticals and as a speaker for Teva Pharmaceutical. Dr. Jimenez-Shahed has received research support from Acadia Pharmaceuticals, Avid Radiopharmaceuticals, Biotie/Acorda Therapeutics, Medtronic, the Michael J. Fox Foundation, and St. Jude Medical; she has received honoraria as a consultant for Teva Pharmaceutical and St. Jude Medical/Abbott; and she has received honoraria from Medtronic. All other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share